If you liked this article you might like

Which Stocks Hurt Billionaire Portfolios the Most in 2014?
Why Enzymotec (ENZY) Plunged to a One-Year Low Today
Enzymotec: John Paulson Bought 20 Percent - Should You Follow Suit?
Medical IPOs: Foundation, Enzymotec and Premier